Xylem (NYSE:XYL) & IHI (OTCMKTS:IHICY) Financial Review

IHI (OTCMKTS:IHICY – Get Free Report) and Xylem (NYSE:XYL – Get Free Report) are both large-cap industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

Institutional and Insider Ownership

88.0% of Xylem shares are held by institutional investors. 0.3% of Xylem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk and Volatility

IHI has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, Xylem has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

Dividends

IHI pays an annual dividend of $0.07 per share and has a dividend yield of 0.5%. Xylem pays an annual dividend of $1.72 per share and has a dividend yield of 1.8%. IHI pays out 6.1% of its earnings in the form of a dividend. Xylem pays out 38.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Xylem has raised its dividend for 2 consecutive years. Xylem is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Ratings

This is a breakdown of recent ratings and price targets for IHI and Xylem, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IHI 0 1 0 0 2.00
Xylem 2 8 9 0 2.37

Xylem has a consensus target price of $121.31, indicating a potential upside of 26.72%. Given Xylem’s stronger consensus rating and higher probable upside, analysts plainly believe Xylem is more favorable than IHI.

Valuation and Earnings

This table compares IHI and Xylem”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IHI $10.92 billion 1.41 $1.06 billion $1.15 12.37
Xylem $9.04 billion 2.43 $957.00 million $4.52 21.18

IHI has higher revenue and earnings than Xylem. IHI is trading at a lower price-to-earnings ratio than Xylem, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares IHI and Xylem’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IHI 11.10% 28.06% 7.62%
Xylem 11.94% 12.06% 7.51%

Summary

Xylem beats IHI on 12 of the 17 factors compared between the two stocks.

About IHI

(Get Free Report)

IHI Corporation is a Japanese engineering and manufacturing company headquartered in Tokyo. Its history dates to the founding of Ishikawajima Shipyard in 1853. The company was formed through the 1960 merger of Ishikawajima Heavy Industries and Harima Shipbuilding & Engineering, and adopted the name IHI Corporation in 2007. IHI designs and supplies equipment and systems for energy and industrial applications, including boilers, turbines, compressors and machinery for plants. It also works on infrastructure such as bridges and other large structures, as well as transportation and industrial systems.

About Xylem

(Get Free Report)

Xylem Inc. is a water technology company that develops equipment, software and services for managing water and wastewater. Its offerings include pumps and treatment systems, water-quality testing and analysis, smart meters, monitoring and control technologies, and services for detecting leaks and maintaining water infrastructure. The company serves water and wastewater utilities, industrial and commercial customers, and residential markets. Its technologies support the movement, treatment, testing and efficient use of water across municipal and industrial systems.

Receive News & Ratings for IHI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IHI and related companies with MarketBeat.com's FREE daily email newsletter.